REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 152 filers reported holding REATA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $150,089,505 | +16.2% | 1,472,043 | +3.6% | 0.03% | +7.7% |
Q1 2023 | $129,212,049 | +125.6% | 1,421,162 | -5.8% | 0.03% | +136.4% |
Q4 2022 | $57,284,437 | +45.0% | 1,507,882 | -4.1% | 0.01% | +37.5% |
Q3 2022 | $39,511,000 | -67.6% | 1,572,266 | -60.8% | 0.01% | -68.0% |
Q2 2022 | $121,853,000 | -15.4% | 4,009,660 | -8.8% | 0.02% | 0.0% |
Q1 2022 | $144,030,000 | +28.4% | 4,396,539 | +3.4% | 0.02% | +38.9% |
Q4 2021 | $112,150,000 | -73.7% | 4,252,977 | +0.2% | 0.02% | -75.3% |
Q3 2021 | $426,917,000 | -30.3% | 4,243,272 | -1.9% | 0.07% | -28.4% |
Q2 2021 | $612,325,000 | +41.0% | 4,326,468 | -0.7% | 0.10% | +34.2% |
Q1 2021 | $434,271,000 | -19.2% | 4,355,767 | +0.2% | 0.08% | -23.2% |
Q4 2020 | $537,219,000 | +38.2% | 4,345,724 | +8.9% | 0.10% | +23.8% |
Q3 2020 | $388,681,000 | -33.4% | 3,989,752 | +6.6% | 0.08% | -38.5% |
Q2 2020 | $583,780,000 | +33.9% | 3,741,699 | +23.9% | 0.13% | +13.0% |
Q1 2020 | $436,039,000 | -10.9% | 3,020,924 | +26.3% | 0.12% | +11.7% |
Q4 2019 | $489,134,000 | +1083.4% | 2,392,674 | +364.8% | 0.10% | +1044.4% |
Q3 2019 | $41,334,000 | -13.2% | 514,810 | +2.0% | 0.01% | -18.2% |
Q2 2019 | $47,607,000 | – | 504,579 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $76,391,000 | 14.09% |
Opaleye Management Inc. | 330,000 | $8,702,000 | 1.85% |
Highlander Partners, L.P. | 27,600 | $728,000 | 0.89% |
Ikarian Capital, LLC | 200,000 | $5,274,000 | 0.79% |
Integral Health Asset Management, LLC | 103,000 | $2,716,000 | 0.75% |
KRS Capital Management, LLC | 32,841 | $866,000 | 0.74% |
Ghost Tree Capital, LLC | 55,000 | $1,450,000 | 0.52% |
MADDEN SECURITIES Corp | 39,312 | $1,037,000 | 0.49% |
LBJ Family Wealth Advisors, Ltd. | 30,359 | $801,000 | 0.47% |
Ikarian Capital, LLC | 100,000 | $2,637,000 | 0.39% |